Inmunotek S.L.
Inmunotek S.L.
Explore linked clinical trials.9 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df | Dust Mite Allergy, Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, Rhinitis, Allergic, immune system disorder, nasal disorder, otorhinolaryngologic disease, perennial allergic rhinitis, respiratory system disorder, respiratory tract infectious disorder, rhinitis | Recruiting | Phase 3 | 2026-01-16 | NCT07348302 | |
| Determination of Blomia Tropicalis Allergen Extract in Prick Test Units | allergic disease, immune system disorder | Not yet recruiting | Not applicable | 2025-10-02 | NCT07195929 | |
| Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses. | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, asthma, bronchial disorder, immune system disorder, lung disorder, nasal disorder, obstructive lung disease, otorhinolaryngologic disease, respiratory system disorder, rhinitis | Recruiting | Phase 3 | 2025-05-13 | NCT04898283 | |
| Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, asthma, bronchial disorder, immune system disorder, lung disorder, nasal disorder, obstructive lung disease, otorhinolaryngologic disease, respiratory system disorder, rhinitis | Recruiting | Phase 3 | 2025-05-13 | NCT04435990 | |
| Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, asthma, bronchial disorder, immune system disorder, lung disorder, nasal disorder, obstructive lung disease, otorhinolaryngologic disease, respiratory system disorder, rhinitis | Recruiting | Phase 3 | 2025-05-07 | NCT04891237 | |
| Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy | Hypersensitivity, Immediate, immune system disorder, venom allergy | Recruiting | Not stated | 2025-05-04 | NCT06782217 | |
| Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions. | Hypersensitivity, Immediate, immune system disorder, venom allergy | Recruiting | Not stated | 2025-05-01 | NCT06790368 | |
| Quercus Ilex and Quercus Robur Allergen Extracts Standardisation | Hypersensitivity, Immediate, Respiratory Hypersensitivity, Rhinitis, Allergic, allergic disease, immune system disorder, nasal disorder, otorhinolaryngologic disease, respiratory system disorder, rhinitis, seasonal allergic rhinitis | Recruiting | Not applicable | 2025-05-01 | NCT05532566 | |
| Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract | Dust Mite Allergy, Hypersensitivity, Immediate, Infections, Respiratory Hypersensitivity, Rhinitis, Allergic, allergic asthma, immune system disorder, nasal disorder, otorhinolaryngologic disease, perennial allergic rhinitis, respiratory system disorder, respiratory tract infectious disorder, rhinitis | Not yet recruiting | Phase 2 / Phase 3 | 2023-10-23 | NCT05641272 |